Year-over-year earnings per share growth for the last twelve months: amarincorp.com (AMRN)

AMRN (Amarin) - company brandmark

Low cash flow predictability due to generic pressure is reducing revenue for Amarin Corporation plc (AMRN). The quarterly EPS trend demonstrates this volatility, where 103.20 shows the current value of the metric. Total reliance on external contractors for substance synthesis exacerbates these risks. Meanwhile, the company's Irish status and focus on Western markets minimize geopolitical threats.

AMRN: amarincorp.com Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/17/2026

Analytical breakdowns for Amarin Corporation plc

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Amarin Corporation plc
Manufactured product of Amarin Corporation plc

Quarterly EPS growth measures the dynamics of net income per share, determining the scaling rate of the business's equity value. This metric reveals the actual efficiency of capital management by excluding random market fluctuations. By analyzing the quarterly EPS change, an investor assesses the impact of Amarin Corporation plc (AMRN) ESG strategies on reducing the production costs of cardiovascular drugs. A stable trend confirms the resilience of a low-carbon footprint model, which allows investors to avoid overpaying for overheated assets.

Competing companies

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|Year-over-year earnings per share growth rate for the last twelve months AVR (Anteris Technologies Ltd)|Tenaya Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CVRx, Inc. CVRX|MIST (Milestone Pharmaceuticals Inc.) - Year-over-year net earnings per share growth for the last 12 months|Cardiol Therapeutics Inc - Year-over-year earnings per one share growth for the last 12 months|BEAT (HeartBeam Corporation) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Tenax Therapeutics Inc|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)